From Harvard Lab to Biotech Startup: Dr. Samir Mitragotri on Drug Delivery Innovation

What if the next breakthrough in medicine doesn't come from biology alone—but from engineering? Innovation is often associated with complexity—but what if the most impactful breakthroughs come from simplifying the problem? In this thought-provoking conversation, Dr. Samir Mitragotri shares how his journey from chemical engineering to bioengineering has shaped his philosophy of innovation, entrepreneurship, and translational science. In episode 9 of Biologics Platform Conversations, Dr. Mitragotri, Hiller Professor, Harvard University, discusses why innovation is inherently risky to exploring the challenges of targeted drug delivery, scaling scientific discoveries into real-world solutions, and the unique role of academia as a catalyst for innovation, this episode offers valuable lessons for scientists, engineers, entrepreneurs, and anyone passionate about advancing healthcare LinkedIn:   / samir-mitragotri-011971   If you're a scientist, engineer, entrepreneur, student, or biotech professional, this episode offers practical insights into navigating research, innovation, and the future of healthcare. Chapters: 00:00 - Intro 00:50 - Who’s Samir Mitragotri 01:33 - Journey of engineer to biologist 03:40 - Magic in Drug Discovery and Delivery 05:10 - Understand the game of Innovations 06:25 - Opportunities for Indian Researchers 07:30 - Academia as Prime spot for Innovation 08:40 - Balancing Innovation and Commercialbility 10:20 - World of Drug Delivery Start-ups 11:16 - How to Scale-up your Innovation? 12:10 - 3 magical words by Dr. Samir 13:46 - Benefits of Conferences 15:10 - RAPID FIRE!!! 15:40 - Outro Connect with us : Website: https://www.biologicsworkshop.com/ LinkedIn:   / biologics-workshop   Instagram:   / biologicsworkshop   Twitter: https://x.com/Biologics_W Youtube:    / @biologicsworkshop   Subscribe and Stay tuned for More! Disclaimer: The views expressed are those of the speaker and do not necessarily reflect those of the organizers. This content is for informational and professional purposes only. #biologics #biosimilars #academia #MumbaiBiocluster #biopharma #biotechnology #LifeSciences #Biomanufacturing #healthcare #innovation #biotech #ecosystem